AbCellera Biologics Inc.ABCLNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank96
5Y CAGR-53.1%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
-53.1%/yr
Long-term compound
Percentile
P96
Near historical high
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 18.46% |
| Q3 2025 | -4.39% |
| Q2 2025 | -1.82% |
| Q1 2025 | -4.14% |
| Q4 2024 | -1.95% |
| Q3 2024 | -3.17% |
| Q2 2024 | -2.18% |
| Q1 2024 | -2.54% |
| Q4 2023 | -3.06% |
| Q3 2023 | -1.21% |
| Q2 2023 | -1.52% |
| Q1 2023 | -2.47% |
| Q4 2022 | -1.73% |
| Q3 2022 | 2.85% |
| Q2 2022 | 0.16% |
| Q1 2022 | 16.04% |
| Q4 2021 | 7.24% |
| Q3 2021 | -3.86% |
| Q2 2021 | 0.17% |
| Q1 2021 | 15.25% |
| Q4 2020 | 817.74% |
| Q3 2020 | -20.48% |
| Q2 2020 | 0.00% |
| Q1 2020 | -100.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |